On October 25th, 2023, the GMP Collective presented the latest installment in their webinar series, When Things Go Wrong.
For episode 15 in the When Things Go Wrong Webinar Series, the GMP Collective presented "From Regulation to Reality: Navigating Risks in the Cannabis Processing World," an hour-long dive into the importance of safety, how to build and design successful facilities, and guidance for collaboration between regulators and stakeholders. The webinar was introduced by GMP Collective founder David Vaillencourt; moderated by Alexa Wilson, director of sales for Omega Equipment; and the two industry expert panelists were Sean Winfield, Chief Marketing Officer and ExtractionTek Stainless and Chris Witherell, CEO of Pressure Safety Inspectors (PSI).
To begin, the panelists shared their years-long journeys into the cannabis industry, the challenges facing facilities, and the disconnect between regulators and end users. They also covered topics including industry landscape, regulatory hurdles, operational challenges, financial implications, and safety and quality control. Viewers had the opportunity to ask questions directly to the panelists.
Winfield discussed navigating challenges in the economy, new opportunities, and changing regulations. “It’s an ever-evolving process. We are 10 years into a novel industry…We’re just past infancy at this point and we still have a long road in front of us when it comes to both the regulatory committee community as well as the design community. We still have a lot of progress to be made.”
Witherell addressed engineering aspects of facilities, including codes, cost, equipment, and accountability. “It’s important that everybody buys into the accountability in the process when it comes to extraction…Creating that accountability is good for everybody in the industry. And the client in the end is really the one that benefits.”
To conclude the webinar, Vaillencourt left attendees with a message encouraging a collaborative spirit within the industry because of what is at stake and how much there is still to learn.
To view the recording or learn more, view the When Things Go Wrong Webinar Series on the GMP Collective website.
The Top 10 Articles from Cannabis Science and Technology in 2024
January 7th 2025It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2024. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
The Top 10 Articles from Cannabis Science and Technology in 2024
January 7th 2025It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2024. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
2 Commerce Drive
Cranbury, NJ 08512